|
Real-time Estimate
Cboe BZX
14:40:11 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 26.52 USD | +3.98% |
|
+7.08% | +49.89% |
| 08-05 | Tranche Update on OrthoPediatrics Corp.'s Equity Buyback Plan announced on August 5, 2024. | CI |
| 08-05 | Truist Adjusts Price Target on OrthoPediatrics to $22 From $20, Maintains Hold Rating | MT |
Company Valuation: OrthoPediatrics Corp.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,178 | 909.5 | 759.2 | 561.3 | 445.4 | 665.8 | - | - |
| Change | - | -22.79% | -16.52% | -26.07% | -20.66% | 49.49% | - | - |
| Enterprise Value (EV) | 1,178 | 909.5 | 759.2 | 561.3 | 445.4 | 665.8 | 665.8 | 665.8 |
| Change | - | -22.79% | -16.52% | -26.07% | -20.66% | 49.49% | 0% | 0% |
| P/E | -71.3x | 662x | -35.3x | -14.1x | -10.5x | -20.9x | -31.3x | -67.5x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -6x | 0x | -0.2x | -3.44x | 0.8x | 0.9x | 1.3x |
| Capitalization / Revenue | 12x | 7.44x | 5.1x | 2.74x | 1.88x | 2.49x | 2.23x | 2x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.49x | 2.23x | 2x |
| EV / EBITDA | -0.01x | 0x | 0x | 0x | 0x | 26.7x | 18x | 13.7x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -34.3x | -49x | -214x |
| EV / FCF | - | - | - | - | - | 476x | 111x | 65.3x |
| FCF Yield | - | - | - | - | - | 0.21% | 0.9% | 1.53% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.84 | 0.06 | -0.92 | -1.64 | -1.69 | -1.221 | -0.815 | -0.3775 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 98.05 | 122.3 | 148.7 | 204.7 | 236.3 | 267 | 298.8 | 333.6 |
| EBITDA 1 | -0.182 | 0.227 | 5.04 | 8.519 | 14.76 | 24.96 | 36.89 | 48.47 |
| EBIT 1 | -18.02 | -25.4 | -26.75 | -35.01 | -39.24 | -19.42 | -13.59 | -3.113 |
| Net income 1 | -16.26 | 1.258 | -20.97 | -37.82 | -39.65 | -28.77 | -18.48 | -8.946 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 59.86 | 39.73 | 32.51 | 23.18 | 17.76 | 25.50 | 25.50 | 25.50 |
| Nbr of stocks (in thousands) | 19,678 | 22,892 | 23,353 | 24,216 | 25,077 | 26,110 | - | - |
| Announcement Date | 3/2/22 | 2/28/23 | 3/6/24 | 3/4/25 | 2/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -20.88x | - | - | - | 666M | |
| 25.74x | 4.99x | 17.15x | 1.09% | 127B | |
| 18.85x | 2.39x | 9.31x | 2.71% | 12.65B | |
| -227.66x | 15.46x | 1835.73x | -.--% | 10.86B | |
| 21.94x | 10.2x | 17.11x | 1.98% | 4.36B | |
| 26.35x | - | - | - | 2.67B | |
| -1331.32x | 1.54x | 7.23x | -.--% | 1.66B | |
| 17.71x | 4.78x | 9.33x | 3.46% | 1.65B | |
| Average | -183.66x | 6.56x | 315.98x | 1.54% | 20.2B | |
| Weighted average by Cap. | -6.12x | 5.61x | 141.08x | 1.18% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- KIDS Stock
- Valuation OrthoPediatrics Corp.
Select your edition
All financial news and data tailored to specific country editions
